DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Boumpas DT, Furie R, Manzi S. et al; BG9588 Lupus Nephritis Trial Group.
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Arthritis Rheum 2003;
48 (03) 719-727
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.